Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial
Annals of Neurology , 08/24/09
Molina CA et al. – Perflutren lipid mu S can be safely combined with systemic tPA and ultrasound at a dose of 1.4ml. Safety concerns in the second dose tier may necessitate extended enrollment and further experiments to determine the mechanisms by which microspheres interact with tissues. In both dose tiers, sonothrombolysis with mu S and tPA shows a trend toward higher early recanalization and clinical recovery rates compared to standard intravenous tPA therapy.
Today in Neuroradiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease
Brain, 12/05/09
Radiation Schedules in Relation to Obliteration and Complications in Hypofractionated Conformal Stereotactic Radiotherapy of Arteriovenous Malformations
Stereotactic and Functional Neurosurgery , 12/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


